BOKF vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BOKF exhibits weak financial health with a Piotroski F-Score of just 2/9, signaling significant concerns in profitability, leverage, and operating efficiency. Despite this, the company shows strong recent earnings growth (YoY EPS +17%, Q/Q +11.7%) and beats earnings estimates in 3 of the last 4 quarters, supporting its current valuation above the Graham Number of $141.93. Profit margins and ROA are solid for the banking sector, but missing data on key leverage and liquidity ratios, along with insider selling, raise caution. The stock trades near analyst target ($134.30) with mixed technicals and low insider sentiment, warranting a cautious hold despite attractive yield and growth.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BOKF vs JPM: Head-to-Head Comparison
This page compares BOK Financial Corporation (BOKF) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.